Dr. Andrew Jackson Sellers, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Wahoo Ave, Groton, CT 06349 Phone: 860-694-4123 |
Dr. William J Aberizk Jr., MD Radiology - Radiation Oncology Medicare: Not Enrolled in Medicare Practice Location: 166 Ledgewood Rd, Apt 108, Groton, CT 06340 Phone: 860-614-3066 |
Dr. Sarojini Bhide Hayne, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: Naval Ambulatory Care Center, Route 12 Bldg 449 Attn Professional Affairs, Groton, CT 06349 Phone: 860-694-2377 Fax: 860-694-2590 |
Dr. Dana Robert Lacey, M.D. Radiology - Body Imaging Medicare: Not Enrolled in Medicare Practice Location: 1 Wahoo Ave, Groton, CT 06349 Phone: 860-694-2435 |
News Archive
In the latest issue of the journal Nature, Miguel Godinho Ferreira, Principal Investigator at the Instituto Gulbenkian de Ciência (IGC) in Portugal, lead a team of researchers to shed light on a paradox that has puzzled biologists since the discovery of telomeres, the protective tips of chromosomes: while broken chromosome ends generated by DNA damage (such as radiation or cigarette smoke) are quickly joined together, telomeres are never tied to each other, thus allowing for the correct segregation of the genetic material into all cells in our body.
Telcare, Inc., the leader in mobile diabetes management solutions, today announced it has received CE Mark approval to market its cellular-enabled blood glucose meter, the first FDA-cleared mHealth glucose meter, in the European Union.
Patients who had received livers from hepatitis B virus core antibody (HBcAb) positive (indicates prior exposure to hepatitis B) and/or hepatitis C virus (HCV) positive donors had similar graft and patient survival compared to patients who received HBcAb negative or HCV negative livers, according to a study by the University of Pittsburgh's Thomas E. Starzl Transplantation Institute.
The American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP) have proposed new guidelines for the prevention and early detection of cervical cancer.
Oncolytics Biotech Inc. today announced preliminary results from a U.S. Phase 2 clinical trial (REO 017) using intravenous administration of REOLYSIN® in combination with gemcitabine (Gemzar®) in patients with advanced pancreatic cancer. The trial is being conducted at the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio (CTRC).
› Verified 7 days ago